vasomera
Peptideexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2012 (NCT01523067)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- vasomera
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01873885 | Phase 1 | Jun 1, 2013 | New Orleans Center for Clinical Research, PhaseBio Pharmaceuticals Inc. |
| NCT01523067 | Phase 1 | Jan 1, 2012 | PhaseBio Pharmaceuticals Inc., Prism Research |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| PhaseBio Pharmaceuticals Inc. | For profit | 2 | 2 | 1 | 2012 |
| New Orleans Center for Clinical Research | For profit | 1 | 0 | 1 | 2013 |
| Prism Research | For profit | 1 | 0 | 1 | 2012 |
3 organizations
Page 1 / 1